date,title,source
Oct-19-18,"New Research Coverage Highlights Himax Technologies, Corporacion America Airports S.A, Tecnoglass, Jounce Therapeutics, Hollysys Automation Technologies, and Obsidian Energy  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-05-18,"Analysts Estimate Jounce Therapeutics, Inc. (JNCE) to Report a Decline in Earnings: What to Look Out for",Zacks
Nov-06-18,"Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018",GlobeNewswire
Nov-13-18,Edited Transcript of JNCE.O earnings conference call or presentation 13-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-13-18,"Jounce Therapeutics, Inc. (JNCE) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-13-18,Jounce Therapeutics Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-20-18,Edited Transcript of JNCE.O earnings conference call or presentation 13-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-28-18,"Report: Exploring Fundamental Drivers Behind Matrix Service, NantHealth, Earthstone Energy, Jounce Therapeutics, BeiGene, and Oxford Immunotec Global  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Jan-02-19,Jounce Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-03-19,"Jounce Therapeutics Completed Enrollment in First Cohort of Phase 1 Clinical Trial with its PD-1 Inhibitor, JTX-4014",GlobeNewswire
Jan-08-19,Edited Transcript of JNCE.O earnings conference call or presentation 13-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
